InvestorsHub Logo
Followers 8
Posts 303
Boards Moderated 0
Alias Born 01/02/2018

Re: None

Tuesday, 10/08/2019 10:46:45 AM

Tuesday, October 08, 2019 10:46:45 AM

Post# of 35961
Royal Society of Chemistry -"In addition to its physiological importance, SERCA is the
target for Mipsagargin (G202), a drug candidate for treatment
of prostate cancer and hepatocellular carcinoma derived from
the natural product thapsigargin (TG)"

https://pubs.rsc.org/en/content/articlelanding/2019/cp/c9cp04736k#!divAbstract
The article was received on 26 Aug 2019, accepted on 17 Sep 2019 and first published on 17 Sep 2019

$NSPX STONGER
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RBSH News